Clinical Trial Update: Single-dose PK Study of Ceftazidime-Avibactam In Hospitalized Children Receiving Systemic Antibiotics for Nosocomial Pneumonia [Phase 1]

View source ↗

Summary

Phase 1 single-dose pharmacokinetic study of ceftazidime-avibactam in hospitalized children receiving systemic antibiotics for suspected or confirmed nosocomial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hospital-acquired Pneumonia
• Nosocomial Pneumonia

Drugs mentioned

• ceftazidime/avibactam (ceftazidime/avibactam)

Snippet

Sponsor: Pfizer | Conditions: Hospitalized Children With Suspected or Confirmed Nosocomial Pneumonia | Phase 1 | Status: TERMINATED | Results posted: 2022-09-09